Angela Minassian
Recent publications
-
An experimental model of clinical immunity for human malaria
Hou MM. et al, (2025)
-
Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled phase 2b trial in children
Natama HM. et al, (2024)
-
Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine development.
Mertens JE. et al, (2024), Vaccine, 42, 3621 - 3629
-
First Phase 1b, single-center, age de-escalation trial of theP. falciparumblood-stage malaria vaccine candidate RH5.1/Matrix-M™: a delayed boost regimen induces high levels of functional antibodies in 5-17 month old Tanzanian infants
Silk SE. et al, (2024)